HFC Raises Over $325K and Connects Over 2000 Supporters for Alzheimer’s Awareness During First Virtual Game Show, Hosted by Seth Rogen

National Alzheimer's Nonprofit Takes Annual Fundraising Virtual With Celebrity-Hosted, 70s-Themed Game Show Featuring Elizabeth Banks, Anna Faris, Jim Gaffigan, Billy Eichner and Craig Robinson.

October 23, 2020

HFC (Seth Rogen and Lauren Miller Rogen’s national nonprofit organization) announced over $325,000 raised during their first virtual fundraising event, Hilarity For Charity’s Head To Head presented by Biogen which was held on Wednesday, October 21st, connecting over 2,000 supporters across the world via Zoom.

HFC is an organization dedicated to caring for families impacted by Alzheimer’s, educating young people about living a brain-healthy life, and accelerating progress in Alzheimer’s care and prevention-focused research.

Taking their annual fundraising event virtual for the first time, Hilarity For Charity’s Head To Head presented by Biogen was an evening full of laughs as celebrity team captains, Anna Faris, Billy Eichner, Craig Robinson, Elizabeth Banks and Jim Gaffigan, faced off against each other in a 70s-themed game show while raising money for HFC. The funds raised will help to provide free, in-home care relief as well as online support to Alzheimer’s caregivers and fund brain-health education and Alzheimer’s-prevention research.

“Lauren and I created HFC to raise awareness and reduce the stigma surrounding Alzheimer’s. HFC is a resource for families who are dealing with Alzheimer’s and our goal is to continue to help fund prevention focused research,” said HFC co-founder, Seth Rogen. “We couldn’t be more grateful for the supportive response we’ve experienced so far and will continue to use laughter to keep the conversation moving forward.”

“My mom, Adele, was diagnosed with Alzheimer’s disease when she was only 55 years old. We do these HFC events so that we can bring awareness and further resources for other families that need it. We are excited to connect with our community virtually and continue to raise awareness for a disease that is so stigmatized and underserved.”

The virtual event was made possible by the generous support of sponsors including: Biogen, Home Instead Senior Care, Crown Royal, Lionsgate, Amazon Studios, Point Grey, OLLY, Dr. and Mr. Buffaloe, Roddenberry Foundation, American Express, Comcast NBCUniversal, Whoop, Lilly and La Croix.

SourceHFC

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”